Latest Latent autoimmune diabetes Stories
(Ivanhoe Newswire) -- A major international study collating and analyzing worldwide data on diabetes since 1980 has found that the number of adults with the disease reached 347 million in 2008, more than double the number in 1980. The research shows that the prevalence of diabetes has risen or at best remained unchanged in virtually every part of the world over the last three decades.Diabetes occurs when the cells of the body are not able to take up sugar in the form of glucose. As a...
ROCKVILLE, Md., June 27, 2011 /PRNewswire-USNewswire/ -- Results of two studies testing drugs to slow or stop the immune system's attack on insulin-producing cells in people newly diagnosed with type 1 diabetes will be presented at the American Diabetes Association's (ADA) 71st Scientific Sessions in San Diego and simultaneously published online in the Lancet. The studies were conducted by the National Institutes of Health's international network of researchers, Type 1 Diabetes TrialNet...
The life expectancy of people diagnosed with type 1 diabetes dramatically increased during the course of a 30-year, long-term prospective study, according to a University of Pittsburgh Graduate School of Public Health study being presented at the 71st Scientific Sessions of the American Diabetes Association.The life expectancy for participants diagnosed with type 1 diabetes between 1965 and 1980 was 68.8 years "“ a 15-year improvement, compared to those diagnosed between 1950 and 1964,...
A major international study recently found that diabetes cases have more than doubled to 347 million cases since 1980, a number far larger than what experts previously thought and one that suggests costs of treating the disease will also skyrocket. The research, published in the journal "˜The Lancet,' reveals that from 1980 to 2008, diabetes has either risen or gone unchanged in every region of the world. The estimated number of diabetics is much higher than a previous projection that placed...
LA JOLLA, Calif., June 24, 2011 /PRNewswire/ -- Cebix Incorporated announced today that preclinical data for its long-acting form of C-peptide, Ersatta(TM) (CBX129801), demonstrated a half-life of three days as compared to one hour for native C-peptide. Ersatta halted the impairment in nerve conduction velocity, a measure of the rate at which electrical signals travel through the nerves, in an animal model of diabetic peripheral neuropathy. Additionally, clinical data showed that native...
Concerns about progress, patient access voiced at Senate hearing for JDRF's Children's Congress WASHINGTON, June 22, 2011 /PRNewswire-USNewswire/ -- Kevin Kline and four children with type 1 diabetes urged the Food and Drug Administration (FDA) to take immediate action to accelerate the research and review of artificial pancreas systems at a hearing before the Senate Committee on Homeland Security and Government Affairs. The hearing, "Transforming Lives through Diabetes Research," was part...
PRINCETON, N.J., June 22, 2011 /PRNewswire/ -- Actor Chris Noth and Novo Nordisk, a world leader in diabetes care, have teamed up in a national education program, Ask.Screen.Know., to highlight the need for early diabetes screening and detection in light of the continuing escalation of diabetes prevalence. As an ambassador for the program, the award-winning actor currently appearing on CBS' show "The Good Wife" and known for his roles as Detective Mike Logan on "Law and Order" and Mr. Big...
Better glucose, lipid and blood pressure control in the diabetic population has not reduced the incidence of kidney damageDiabetic kidney disease has become more prevalent in the United States over the past 20 years, despite a substantial increase in the use of medications for the treatment of people with diabetes, according to a study to be published June 22 in JAMA, the Journal of the American Medical Association.These medications include drugs that lower glucose, blood pressure and...
WASHINGTON, June 20, 2011 /PRNewswire-USNewswire/ -- On Wednesday, actor Kevin Kline and children with type 1 diabetes from all over the country will testify before the Senate Committee on Homeland Security and Government Affairs to thank Congress for its renewal last December of the Special Diabetes Program and highlight the importance of the federal government's commitment in helping to advance type 1 diabetes research. They will also urge federal officials to take immediate action to...
LA JOLLA, Calif., June 16, 2011 /PRNewswire/ -- Cebix Incorporated announced today it is advancing the development of modified C-peptide for the treatment of complications of diabetes. The biopharmaceutical company has initiated a Phase 1b clinical trial to evaluate Ersatta(TM), its proprietary long-acting form of C-peptide, in patients with type 1 diabetes who, because of their disease, lack this endogenous peptide. Following the successful completion of this study, the company is...
